Award Year / Program / Phase:1984 / SBIR / Phase II
Agency:HHS
Principal Investigator:Richard J. Baranczuk
Award Amount:$269,150.00
Abstract:
The high incidence of breast cancer in women makes this disease the leading cancer type in this population. the proper staging of this cancer and the determination of the presence or absence of estrogen receptors play major roles in determining the course of treatment. presently availablemethods for… More
Award Year / Program / Phase:1985 / SBIR / Phase I
Agency:HHS
Principal Investigator:Richard j. baranczuk , PRINCIPAL INVESTIGATOR
Award Amount:$48,249.00
Abstract:
Anti-idiotypic monoclonal antibody (aima) therapy has curative potential for low-grade b-cell lymphomas through immunologic down regulation of the malignant idiotypic clone as well as antibody-dependent cell mediated cytotoxicity. production of aima is patient-specific and labor intensive requiring… More